ROXANNE BOYD: Open Payments
NPI 1801281191 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 53 payments from 18 companies in 2025. Trend: 2023 $996 · 2024 $1,079 · 2025 $1,061
Food & beverage: $1,018Education: $43
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $145 |
| Verona Pharma, Inc. | 4 | $101 |
| Lilly USA, LLC | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Viatris Specialty LLC | 4 | $74 |
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| Mannkind Corporation | 1 | $43 |
| Abbott Laboratories | 2 | $38 |
| ABBVIE INC. | 2 | $37 |
Products named: Auvelity, CAPLYTA, Ohtuvayre, REXULTI, YUPELRI, JARDIANCE, AFREZZA, FREESTYLE LIBRE 3.
Industry payments across LA — which companies pay providers there.
